Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults with very poor prognosis and few advances in its treatment. Recently, fast-growing cancer immunotherapy provides a glimmer of hope for GBM treatment. Adoptive cell therapy (ACT) aims at infusing immune cells with direct a...
Main Authors: | Jingyu Wang, Fang Shen, Ying Yao, Lin-lin Wang, Yongjian Zhu, Jue Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00059/full |
Similar Items
-
T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies
by: Valérie Janelle, et al.
Published: (2021-02-01) -
Cellular immunotherapies for cancer
by: Pedro Berraondo, et al.
Published: (2017-05-01) -
Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
by: Ratchapong Netsrithong, et al.
Published: (2021-09-01) -
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
by: Michael C. Burger, et al.
Published: (2019-11-01) -
Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma
by: Michael P Brown, et al.
Published: (2019-01-01)